Search results
Nurix Therapeutics CFO Hans van Houte sells $400k in company stock By Investing.com
Investing.com· 1 day agoIn a recent stock transaction, Hans van Houte, Chief Financial Officer of Nurix Therapeutics, Inc....
argenx shares hold as Piper Sandler keeps Overweight rating By Investing.com
Investing.com· 5 days agoOn Monday, Piper Sandler maintained a positive stance on argenx SE (NASDAQ:ARGX), reiterating an...
Resurrecting an Old Therapy Against a Growing Antibiotic Crisis
WebMD· 2 days agoThomas Patterson was on vacation in Egypt with his wife when he first became sick. Patterson was infected with Acinetobacter baumannii, which the World Health Organization would later name the ...
How Crypto Money Is Poised to Influence the Election
New York Times· 5 days agoTrump wanted him to come to the stage and say a few words. Mr. Selkis, who runs the crypto data firm Messari, was one of a couple hundred attendees at an...
The 3 Best Medical Device Stocks to Buy in June 2024
InvestorPlace· 1 day agoMedical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical...
TD Cowen starts Alkermes stock coverage with Buy By Investing.com
Investing.com· 5 days agoOn Monday, TD Cowen initiated coverage on shares of Alkermes (NASDAQ:ALKS), assigning a Buy rating...
Kapitalo Investimentos Ltda Makes New $150,000 Investment in Wyndham Hotels & Resorts, Inc....
ETF DAILY NEWS· 3 days ago(NYSE:WH – Free Report) during the fourth quarter, according to the company in its most recent...
80,409 Shares in Air Products and Chemicals, Inc. (NYSE:APD) Purchased by Confluence Investment...
ETF DAILY NEWS· 3 days agoConfluence Investment Management LLC bought a new stake in Air Products and Chemicals, Inc....
Emergent BioSolutions sells Baltimore facility to Bora Pharmaceuticals By Investing.com
Investing.com· 2 days ago(NYSE: EBS), a biopharmaceutical company, has struck a deal to divest its Baltimore-Camden drug...
Qiagen Lays out Four-Year Plan to Achieve 7 Percent CAGR
GenomeWeb News· 3 days agoYork Stock Exchange on Tuesday, Qiagen guided analysts through a focused growth investment case aimed at maintaining a 7 percent compound annual growth rate at constant exchange ...